Search results for: Kenneth Arrow

Capturing the lived experiences of informal care in acute leukemia

20 November 2025

…heavy toll on both patients and carers Acute leukemia is a group of aggressive cancers that affect the blood and bone marrow. Acute leukemia progresses rapidly, requires intensive treatment and often…

Employer Costs from Respiratory Infections

16 December 2024

Share this: Download publication Helen Hayes Brittany Darrow Lotte Steuten Graham Cookson Amanda Cole Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs…

The Importance of Diversity of Supply in Rare Diseases Markets

23 January 2025

Share this: Download publication Matthew Napier Brittany Darrow Matthias Hofer Mikel Berdud Amanda Cole Rare disease medicine markets often rely on single suppliers, increasing the risk of shortages and limiting…

Understanding the Full Value of Long-Acting Therapies: less is more?

7 May 2025

…footprint compared to shorter- acting alternatives. Realising the potential value of long-acting therapies is currently hindered by a narrow view of value in health technology assessment (HTA) and variability across…

Advancing Rare Disease Care: Challenges and Key Issues

28 February 2025

…update makes some of the routing criteria more explicit, eligibility continues to apply to only a narrow subset of rare disease treatments. The graph below demonstrates that – for orphan…

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

1 May 2025

Share this: Download publication Brittany Darrow Sulayman Chowdhury Phill O’Neill Nadine Henderson The National Institute for Health and Care Excellence (NICE) is the body responsible for recommending medicines for use…

Taking STRIDES: The value of diagnostics against AMR

10 June 2025

…and projecting public health: Spectrum value: Enables use of narrow-spectrum antibiotics by identifying specific pathogens and resistance patterns. Transmission value: Reduces the spread of infectious and resistant pathogens through earlier detection and…

Our team

…Paul Oyalo Economist Brittany Darrow Economist Henry Fong Economist Angus Macfarlane Graduate Economist Louis Zanden Graduate Economist Grainne Cremin Graduate Economist Bradley Barker‑Jones Graduate Economist Libby Tungate Fellow Aisha Aidarous…

The commercial case for investing in ALS

13 November 2025

Share this: Download publication Brittany Darrow Priscila Radu Amanda Cole Key takeaways Unmet need: Diagnosis is often delayed, and few disease-modifying therapies exist, offering only modest benefits or limited applicability…